Amplified Sciences key facts
as of Oct 2026- Developer of a diagnostic test platform designed for the detection of debilitating diseases across oncology and chronic kidney disease.
- Amplified Sciences is valued at approximately $9.0M as of Oct 2026 (last reported valuation).
- It has raised $11.2M across 3 recorded rounds; the latest was Seed Round ($3.0M) in Aug 2025.
- Notable investors include Plug and Play Tech Center, US National Science Foundation, MedTech Innovator, National Institutes of Health, Keiretsu Forum — 32 tracked in total.
- Amplified Sciences has filed 6 Form Ds with the SEC since 2020, most recently Feb 2026 ($3.0M sold to 41 investors).
- Status: Privately Held (backing).
Amplified Sciences's last reported valuation, Dec 2023. Nothing priced has surfaced since.
- ·The complete investor list: 32 names
- ·Watch Amplified Sciences: the Monday email on marks, rounds and moves
Amplified Sciences funding rounds
3 roundsWho backs Amplified Sciences
32+Amplified Sciences valuation
Amplified Sciences's last reported valuation was $9 million in Dec 2023. No priced round, secondary trade or fund mark has surfaced since.
How much has Amplified Sciences raised?
Amplified Sciences has raised $11.2 million across 3 recorded rounds since 2019. The largest was a $3 million seed round in Aug 2025.
Amplified Sciences has filed 6 Form Ds with the SEC since 2020, most recently in Feb 2026 ($3 million sold to 41 investors).
Amplified Sciences investors
32 investors are on record for Amplified Sciences, including Plug and Play Tech Center, US National Science Foundation, MedTech Innovator and National Institutes of Health. The seed round in Aug 2025 drew 41 investors.
About Amplified Sciences
Developer of a diagnostic test platform designed for the detection of debilitating diseases across oncology and chronic kidney disease. The company's platform offers a sensitive optical reporter system integrated with machine learning and multi-analyte assays, which helps to detect biomarker levels and activity in minute volumes of pancreatic cyst fluid for patients at risk for pancreatic cancer diagnosed with pancreatic cystic lesions, enabling clinicians focused on the detection of diseases like pancreatic cancer to improve outcomes and reduce unnecessary procedures.
- Sector
- Healthcare
- HQ
- West Lafayatte, IN, United States
- Founded
- 2016
- Employees
- 7
- Website
- amplifiedsciences.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.